These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 37620233)

  • 1. Re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging After Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.
    Abreu-Gomez J; Haider M; Ghai S
    Eur Urol Oncol; 2024 Feb; 7(1):169-170. PubMed ID: 37620233
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Jorge Abreu-Gomez, Masoom Haider, and Sangeet Ghai's Letter to the Editor re: Francesco Giganti, Louise Dickinson, Clement Orczyk, et al. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy. Eur Urol Oncol. 2023;6:629-634.
    Giganti F; Dickinson L; Allen C; Moore CM
    Eur Urol Oncol; 2024 Apr; 7(2):308. PubMed ID: 37722978
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy.
    Giganti F; Dickinson L; Orczyk C; Haider A; Freeman A; Emberton M; Allen C; Moore CM
    Eur Urol Oncol; 2023 Dec; 6(6):629-634. PubMed ID: 37210343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
    Lei Y; Han S; Xing N
    Eur Urol; 2022 May; 81(5):e121. PubMed ID: 35125229
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019.
    Samaratunga H; Delahunt B; Egevad L
    Eur Urol; 2022 Jul; 82(1):e15-e16. PubMed ID: 35428506
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Valentin H. Meissner, Isabel Rauscher, Kristina Schwamborn, et al. Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2021.11.019: A Storm in a Teacup.
    Marra G; Stabile A; Gontero P; Montorsi F; Briganti A; Gandaglia G;
    Eur Urol; 2022 May; 81(5):e115-e116. PubMed ID: 35151511
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy. Eur Urol Oncol 2020;7:739-47.
    Morka N; Simpson BS; Emberton M; Norris JM
    Eur Urol Oncol; 2021 Feb; 4(1):127-128. PubMed ID: 33509743
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Chu CE; Lonergan PE; Carroll PR
    Eur Urol; 2020 Sep; 78(3):e110-e111. PubMed ID: 32622551
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Montorsi F; Gandaglia G; Fossati N; Salonia A; Briganti A
    Eur Urol; 2020 Oct; 78(4):e165. PubMed ID: 32798145
    [No Abstract]   [Full Text] [Related]  

  • 10. Utility of Multiparametric MRI for Predicting Residual Clinically Significant Prostate Cancer After Focal Laser Ablation.
    Felker ER; Raman SS; Lu DSK; Tuttle M; Margolis DJ; ElKhoury FF; Sayre J; Marks LS
    AJR Am J Roentgenol; 2019 Dec; 213(6):1253-1258. PubMed ID: 31361529
    [No Abstract]   [Full Text] [Related]  

  • 11. Reply to Francesco Montorsi, Giorgio Gandaglia, Nicola Fossati, Andrea Salonia, and Alberto Briganti's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Oct; 78(4):e166. PubMed ID: 32712048
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Giorgio Gandaglia, Guillaume Ploussard, Massimo Valerio, et al. The Key Combined Value of Multiparametric Magnetic Resonance Imaging, and Magnetic Resonance Imaging-targeted and Concomitant Systematic Biopsies for the Prediction of Adverse Pathological Features in Prostate Cancer Patients Undergoing Radical Prostatectomy. Eur Urol 2020;77:733-41.
    Aning J; McCoubrie P; Oxley J
    Eur Urol; 2020 Nov; 78(5):e198-e199. PubMed ID: 32839000
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of multiparametric and biparametric MRI of the prostate: are gadolinium-based contrast agents needed for routine examinations?
    Junker D; Steinkohl F; Fritz V; Bektic J; Tokas T; Aigner F; Herrmann TRW; Rieger M; Nagele U
    World J Urol; 2019 Apr; 37(4):691-699. PubMed ID: 30078170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Re: Hashim U. Ahmed, Louise Dickinson, Susan Charman, et al. Focal Ablation Targeted to the Index Lesion in Multifocal Localised Prostate Cancer: a Prospective Development Study. Eur Urol 2015;68:927-36.
    Li H; Yan W; Ji Z
    Eur Urol; 2016 Nov; 70(5):e131. PubMed ID: 27085626
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate Radiofrequency Focal Ablation (ProRAFT) Trial: A Prospective Development Study Evaluating a Bipolar Radiofrequency Device to Treat Prostate Cancer.
    Orczyk C; Barratt D; Brew-Graves C; Peng Hu Y; Freeman A; McCartan N; Potyka I; Ramachandran N; Rodell R; Williams NR; Emberton M; Ahmed HU
    J Urol; 2021 Apr; 205(4):1090-1099. PubMed ID: 33315505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial, Eur Urol 2024:85:105-111.
    Huang TB; Ding XF
    Eur Urol; 2024 Apr; 85(4):e112. PubMed ID: 38105141
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Matthias Boschheidgen, Peter Albers, Heinz-Peter Schlemmer, et al. Multiparametric Magnetic Resonance Imaging in Prostate Cancer Screening at the Age of 45 Years: Results from the First Screening Round of the PROBASE Trial. Eur Urol 2024;85:105-11.
    Cardona Ortegón JD; Campaña Perilla LA; Olarte Bermúdez LM
    Eur Urol; 2024 Jul; 86(1):e21. PubMed ID: 38644137
    [No Abstract]   [Full Text] [Related]  

  • 18. Detection and staging of radio-recurrent prostate cancer using multiparametric MRI.
    Kowa JY; Soneji N; Sohaib SA; Mayer E; Hazell S; Butterfield N; Shur J; Ap Dafydd D
    Br J Radiol; 2021 Apr; 94(1120):20201423. PubMed ID: 33586998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to Carissa E. Chu, Peter E. Lonergan, and Peter R. Carroll's Letter to the Editor re: Vasilis Stavrinides, Francesco Giganti, Bruce Trock, et al. Five-year Outcomes of Magnetic Resonance Imaging-based Active Surveillance for Prostate Cancer: A Large Cohort Study. Eur Urol 2020;78:443-51.
    Stavrinides V; Giganti F; Emberton M; Moore CM
    Eur Urol; 2020 Sep; 78(3):e112-e113. PubMed ID: 32653326
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Radical Prostatectomy Without Prior Biopsy Following Multiparametric Magnetic Resonance Imaging and Prostate-specific Membrane Antigen Positron Emission Tomography.
    Borghesi M; Bauckneht M; Terrone C
    Eur Urol; 2023 Feb; 83(2):185-186. PubMed ID: 36463074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.